|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 904.80 INR | +1.29% |
|
-7.30% | -0.40% |
| 31/12 | Sai Life Sciences receives tax penalty of 49.3 million rupees | RE |
| 11/12 | Sai Life Sciences receives tax penalty of 32.6 million rupees | RE |
| Capitalization | 19TCr 211.62Cr 181.85Cr 169.58Cr 157.57Cr 294.01Cr 317.03Cr 1.95TCr 766Cr 9.13TCr 793.62Cr 777.35Cr 34TCr | P/E ratio 2026 * |
59x | P/E ratio 2027 * | 49.1x |
|---|---|---|---|---|---|
| Enterprise value | 19TCr 212.07Cr 182.23Cr 169.93Cr 157.91Cr 294.63Cr 317.7Cr 1.95TCr 767.62Cr 9.15TCr 795.3Cr 778.99Cr 34TCr | EV / Sales 2026 * |
8.75x | EV / Sales 2027 * | 7.53x |
| Free-Float |
99.39% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Sai Life Sciences Limited
| 1 day | +1.29% | ||
| 1 week | -7.30% | ||
| Current month | -0.40% | ||
| 1 month | +0.60% | ||
| 3 months | +4.22% | ||
| 6 months | +15.68% | ||
| Current year | -0.40% |
| 1 week | 885.45 |  | 974 |
| 1 month | 865 | | 983.35 |
| Current year | 885.45 | | 983.35 |
| 1 year | 636.1 | | 983.35 |
| 3 years | 636.1 | | 983.35 |
| 5 years | 636.1 | | 983.35 |
| 10 years | 636.1 | | 983.35 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 54 | 01/05/2004 | |
Dean Edney
CTO | Chief Tech/Sci/R&D Officer | - | 06/01/2020 |
Runa Karan
CMP | Compliance Officer | - | 10/04/2008 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 54 | 01/05/2004 | |
| Chairman | 75 | 25/01/1999 | |
| Director/Board Member | 67 | 21/05/2024 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.29% | -7.30% | +27.46% | - | 209.36Cr | |
| -0.35% | +1.24% | +35.07% | +197.88% | 97TCr | |
| +1.87% | +4.33% | +47.89% | +23.19% | 51TCr | |
| +0.32% | -1.42% | +24.90% | +43.72% | 39TCr | |
| -0.47% | +3.33% | +28.69% | +16.87% | 37TCr | |
| -0.79% | -0.21% | +29.44% | +20.18% | 29TCr | |
| -0.18% | +1.90% | +25.17% | +34.49% | 27TCr | |
| -0.85% | -0.56% | +7.21% | -3.55% | 27TCr | |
| +1.11% | +5.29% | -37.48% | -18.15% | 26TCr | |
| -0.38% | -1.78% | +20.03% | +19.35% | 18TCr | |
| Average | +0.27% | +0.57% | +20.84% | +37.11% | 35.1TCr | |
| Weighted average by Cap. | +0.39% | +1.55% | +25.53% | +68.27% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.19TCr 24Cr 21Cr 19Cr 18Cr 34Cr 36Cr 223.37Cr 88Cr 1.05TCr 91Cr 89Cr 3.86TCr | 2.55TCr 28Cr 24Cr 23Cr 21Cr 39Cr 42Cr 259.73Cr 102.05Cr 1.22TCr 105.73Cr 103.56Cr 4.49TCr |
| Net income | 311.39Cr 3.45Cr 2.96Cr 2.76Cr 2.57Cr 4.79Cr 5.17Cr 32Cr 12Cr 148.8Cr 13Cr 13Cr 548.81Cr | 377.35Cr 4.18Cr 3.59Cr 3.35Cr 3.11Cr 5.8Cr 6.26Cr 38Cr 15Cr 180.33Cr 16Cr 15Cr 665.07Cr |
| Net Debt | 40Cr 44.75L 38.45L 35.86L 33.32L 62.17L 67.04L 4.12Cr 1.62Cr 19Cr 1.68Cr 1.64Cr 71Cr | 66Cr 72.57L 62.36L 58.16L 54.04L 1.01Cr 1.09Cr 6.69Cr 2.63Cr 31Cr 2.72Cr 2.67Cr 115.52Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 904.80 ₹ | +1.29% | 2,19,141 |
| 12/26/12 | 893.30 ₹ | -3.25% | 4,92,110 |
| 09/26/09 | 923.30 ₹ | -3.68% | 2,89,345 |
| 08/26/08 | 958.55 ₹ | -0.89% | 2,23,356 |
| 07/26/07 | 967.15 ₹ | -0.92% | 3,04,497 |
End-of-day quote NSE India S.E., January 13, 2026
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SAILIFE Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition